nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—Prostate carcinoma—Riluzole—amyotrophic lateral sclerosis	0.178	0.209	CcSEcCtD
Testosterone Propionate—Prostate cancer—Riluzole—amyotrophic lateral sclerosis	0.0875	0.103	CcSEcCtD
Testosterone Propionate—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.0388	0.0455	CcSEcCtD
Testosterone Propionate—Priapism—Riluzole—amyotrophic lateral sclerosis	0.0347	0.0408	CcSEcCtD
Testosterone Propionate—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0246	0.0289	CcSEcCtD
Testosterone Propionate—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0204	0.0239	CcSEcCtD
Testosterone Propionate—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.0202	0.0238	CcSEcCtD
Testosterone Propionate—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.0192	0.0226	CcSEcCtD
Testosterone Propionate—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0208	CcSEcCtD
Testosterone Propionate—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0178	CcSEcCtD
Testosterone Propionate—COMT—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.0144	0.0984	CbGpPWpGaD
Testosterone Propionate—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0154	CcSEcCtD
Testosterone Propionate—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.013	0.0152	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0148	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0143	CcSEcCtD
Testosterone Propionate—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0142	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0132	CcSEcCtD
Testosterone Propionate—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.011	0.0129	CcSEcCtD
Testosterone Propionate—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00984	0.0116	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00969	0.0114	CcSEcCtD
Testosterone Propionate—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00958	0.0112	CcSEcCtD
Testosterone Propionate—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00895	0.0105	CcSEcCtD
Testosterone Propionate—COMT—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00889	0.0608	CbGpPWpGaD
Testosterone Propionate—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00887	0.0104	CcSEcCtD
Testosterone Propionate—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00847	0.00994	CcSEcCtD
Testosterone Propionate—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00842	0.00989	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00832	0.00977	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00828	0.00972	CcSEcCtD
Testosterone Propionate—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00826	0.0097	CcSEcCtD
Testosterone Propionate—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00764	0.00897	CcSEcCtD
Testosterone Propionate—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00761	0.00893	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00759	0.00891	CcSEcCtD
Testosterone Propionate—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00744	0.00874	CcSEcCtD
Testosterone Propionate—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00738	0.00867	CcSEcCtD
Testosterone Propionate—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00733	0.00861	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0068	0.00799	CcSEcCtD
Testosterone Propionate—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00661	0.00776	CcSEcCtD
Testosterone Propionate—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00633	0.00743	CcSEcCtD
Testosterone Propionate—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00624	0.00733	CcSEcCtD
Testosterone Propionate—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00624	0.00733	CcSEcCtD
Testosterone Propionate—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00622	0.00731	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0062	0.00728	CcSEcCtD
Testosterone Propionate—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00617	0.00724	CcSEcCtD
Testosterone Propionate—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00603	0.00709	CcSEcCtD
Testosterone Propionate—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00598	0.00703	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00598	0.00703	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00587	0.00689	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.00584	0.0399	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00581	0.00683	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00545	0.0064	CcSEcCtD
Testosterone Propionate—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00636	CcSEcCtD
Testosterone Propionate—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00537	0.00631	CcSEcCtD
Testosterone Propionate—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00533	0.00626	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—HNRNPA1—amyotrophic lateral sclerosis	0.00527	0.0361	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00517	0.00607	CcSEcCtD
Testosterone Propionate—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00516	0.00606	CcSEcCtD
Testosterone Propionate—Pain—Riluzole—amyotrophic lateral sclerosis	0.00512	0.00601	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00493	0.00579	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00489	0.00575	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.00486	0.0333	CbGpPWpGaD
Testosterone Propionate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00558	CcSEcCtD
Testosterone Propionate—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00473	0.00556	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.00461	0.0315	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00518	CcSEcCtD
Testosterone Propionate—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00504	CcSEcCtD
Testosterone Propionate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00423	0.00497	CcSEcCtD
Testosterone Propionate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00481	CcSEcCtD
Testosterone Propionate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00396	0.00465	CcSEcCtD
Testosterone Propionate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00447	CcSEcCtD
Testosterone Propionate—Rash—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00443	CcSEcCtD
Testosterone Propionate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00443	CcSEcCtD
Testosterone Propionate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00375	0.0044	CcSEcCtD
Testosterone Propionate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00417	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00246	0.0168	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00239	0.0164	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00235	0.0161	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00231	0.0158	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—SOD1—amyotrophic lateral sclerosis	0.00226	0.0155	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00221	0.0151	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00213	0.0146	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.002	0.0137	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00197	0.0135	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00195	0.0133	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00188	0.0128	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00183	0.0125	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00181	0.0124	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00181	0.0124	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00181	0.0124	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.0017	0.0116	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00169	0.0116	CbGpPWpGaD
Testosterone Propionate—Progesterone—SIGMAR1—amyotrophic lateral sclerosis	0.00166	0.723	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00166	0.0113	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00163	0.0112	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00161	0.011	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.0016	0.011	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00154	0.0105	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00152	0.0104	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00149	0.0102	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00149	0.0102	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00149	0.0102	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00149	0.0102	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00147	0.0101	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00145	0.0099	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00139	0.0095	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00139	0.0095	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00124	0.00851	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00124	0.00846	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.00113	0.0077	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.0011	0.00754	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.0011	0.00752	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00108	0.00741	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00107	0.00732	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00105	0.0072	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00104	0.0071	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00101	0.00689	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000992	0.00679	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000986	0.00674	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.000963	0.00659	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000959	0.00656	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000939	0.00642	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000842	0.00576	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000842	0.00576	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.000819	0.0056	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000806	0.00552	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000806	0.00552	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.000797	0.00545	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000778	0.00532	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000771	0.00527	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00077	0.00527	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000752	0.00514	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00075	0.00513	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000737	0.00504	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00073	0.00499	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000716	0.0049	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000686	0.00469	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000673	0.0046	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000658	0.0045	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000656	0.00449	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000649	0.00444	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000645	0.00441	CbGpPWpGaD
Testosterone Propionate—Drospirenone—PTGS2—amyotrophic lateral sclerosis	0.000637	0.278	CrCbGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000626	0.00428	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—amyotrophic lateral sclerosis	0.000621	0.00425	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—DAO—amyotrophic lateral sclerosis	0.000609	0.00416	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000583	0.00399	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.000506	0.00346	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000504	0.00345	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000504	0.00345	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00047	0.00322	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000461	0.00316	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000461	0.00316	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.000456	0.00312	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000442	0.00302	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000429	0.00293	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSR—amyotrophic lateral sclerosis	0.000426	0.00291	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000426	0.00291	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000408	0.00279	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000403	0.00276	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000395	0.0027	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000385	0.00263	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RARA—amyotrophic lateral sclerosis	0.000384	0.00262	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000371	0.00254	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000365	0.00249	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000353	0.00241	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00035	0.00239	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000336	0.0023	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000335	0.00229	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000328	0.00224	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000327	0.00224	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000305	0.00209	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000278	0.0019	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000276	0.00189	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000255	0.00174	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000254	0.00173	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00021	0.00144	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000209	0.00143	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000209	0.00143	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000188	0.00129	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00018	0.00123	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000173	0.00118	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000165	0.00113	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—APOE—amyotrophic lateral sclerosis	0.000142	0.000972	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000136	0.000931	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000113	0.00077	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000103	0.000708	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.73e-05	0.000666	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.32e-05	0.000638	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	8.51e-05	0.000582	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.83e-05	0.000399	CbGpPWpGaD
